bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.06.14.545014

Predicting T cell activation based on intracellular calcium fluctuations

Abstract

Adoptive T cell therapies rely on the transduction of T cells with a predetermined antigen receptor which redirects their specificity towards tumor-specific antigens. Despite the development of multiple platforms for tumor-specific T cell receptor (TCR) discovery, this process remains time consuming and skewed toward high-affinity TCRs. Specifically, the methods for identifying therapeutically-relevant TCR sequences, predominantly achieved through the enrichment of antigen-specific T cells, represents a major bottleneck for the broader application of TCR-engineered cell therapies. Fluctuation of intracellular calcium levels in T cells is a well described, proximal readout of TCR signaling. Hence, it is an attractive candidate marker for identifying antigen-specific T cells that does not require in vitro antigen-specific T cell expansion. However, calcium fluctuations downstream of TCR engagement with antigen are highly variable; we propose that appropriately-trained machine learning algorithms may allow for T cell classification from complex datasets such as those related to polyclonal T cell signaling events. Using deep learning tools, we demonstrate efficient and accurate prediction of antigen-specificity based on intracellular Ca2+ fluctuations of in vitro-stimulated CD8+ T cells. Using a simple co-culture assay to activate monoclonal TCR transgenic T cells of known specificity, we trained a convolutional neural network to predict T cell reactivity, and we test the algorithm against T cells bearing a distinct TCR transgene as well as a polyclonal T cell response. This approach provides the foundation for a new pipeline to fast-track antigen specific TCR sequence identification for use in adoptive T cell therapy. Significance StatementWhile T cells engineered to express a cancer-specific T cell receptor (TCR) are emerging as a viable approach for personalized therapies, the platforms for identifying clinically-relevant TCR sequences are often limited in the breadth of antigen receptors they identify or are cumbersome to implement on a personalized basis. Here, we show that imaging of intracellular calcium fluctuations downstream of TCR engagement with antigen can be used, in combination with artificial intelligence approaches, to accurately and efficiently predict T cell specificity. The development of cancer-specific T cell isolation methods based on early calcium fluctuations may avoid the biases of current methodologies for the isolation of patient-specific TCR sequences in the context of adoptive T cell therapy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

This, S., Costantino, S., Melichar, H. J.. 2023-06-14. Predicting T cell activation based on intracellular calcium fluctuations. https://doi.org/10.1101/2023.06.14.545014

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

De novo design of CR2 binder as vaccine scaffold

Efficient B cell activation during vaccine-induced humoral immunity relies on both B cell receptor (BCR) antigen recognition and synergistic signaling from co-receptors. Complement receptor 2 (CR2), the primary BCR co-receptor on B cells, lowers the activation threshold and amplifies downstream kinase signaling by orders of magnitude when engaged by complement fragment C3d decorated antigens. Targeting CR2 therefore represents a rational vaccine enhancement strategy, yet native C3d suffers from low affinity, poor stability, and manufacturing challenges. Here, we report the de novo design of a highly stable, high-affinity CR2 binder using deep learning driving protein design methods. Biophysical characterization, high-resolution cryoEM structural determination, and functional assays in vitro and in vivo confirm that the designed binder matches computational design models and specifically engages CR2 to boost B cell activation. When fused to antigen as a vaccine scaffold, the trimeric CR2 binder elicits robust humoral immune responses comparable to nanoparticle vaccines, while retaining the simplicity of single-chain protein production. Our work establishes a modular CR2 targeting vaccine scaffold platform with broad translational potential for next-generation protein vaccines.

immunology↗

Chronic opioid-associated immune dysregulation among people living with HIV

Objectives: Persistent immune dysregulation contributes to chronic disease among people living with HIV (PWH), even after viral suppression with antiretroviral therapy (ART). Although chronic opioid exposure is associated with adverse clinical outcomes, its impact on immune homeostasis during ART remains incompletely understood. We investigated whether opioid use disorder (OUD) is associated with persistent systemic and cellular immune dysregulation despite ART-mediated reductions in HIV viral load (VL). Methods: Peripheral blood was collected longitudinally from PWH with OUD (PWH/OUD+) and detectable HIV VL during 6 months of optimized ART (months 0, 3, and 6). A reference cohort of PWH without OUD (PWH/OUD-) and suppressed HIV VL provided a single blood sample. Immune profiling included plasma inflammatory biomarkers, multiplex cytokine analyses, spectral flow cytometry, and assessment of monocyte cytokine responses following lipopolysaccharide (LPS) stimulation. Mixed-effects models adjusted for HIV VL and VL-stratified analyses were performed. Results: PWH/OUD+ exhibited persistent immune dysregulation despite reductions in HIV VL. Plasma sCD163, sCD14, fractalkine, and I-TAC remained elevated, whereas TGF-{beta}1 was reduced. OUD was associated with expansion of CD16 monocytes and altered expression of CCR2, CD38, and CD11b. CD4 and CD8 T cells, NK cells, and B cells also exhibited persistent alterations in markers of activation, metabolism, and trafficking. Monocytes from PWH/OUD+ displayed attenuated cytokine responses following LPS stimulation. Conclusions: OUD is associated with persistent systemic and cellular immune dysfunction in PWH despite ART-mediated viral suppression, supporting opioid exposure as an independent contributor to chronic immune dysregulation that may promote inflammation, immune dysfunction, and long-term HIV-associated comorbidities. Keywords: HIV, Opioid-use disorder, innate immunity, cytokine

immunology↗

The mitochondrial RNA extrusion-induced innate immunity is regulated by N6-methyladenosine machinery

Mitochondrial RNA (mtRNA) released into the cytosol functions as a damage associated molecular pattern that activates pattern-recognition receptor (PRR)-mediated inflammation, yet its release mechanisms and cytoplasmic fate remain poorly understood. Here we report that chemical Abt-373-treatment and Vesicular stomatitis virus (VSV) infection induce mtRNA extrusion through Bax/Bak and VDAC1 channels, accompanied by mtDNA release. Extruded mtRNA in A549 cells activates multiple cytosolic PRRs, including RIG-I, MDA5, TLR3/7/8, and PKR, each contributing differentially to the innate immune signaling. Analysis of GEO datasets and methylated RNA immunoprecipitation (MeRIP) assays further reveals that mtRNA carries methyladenosine (m6A) modification. m6A machinery proteins are involved in the cytoplasmic retention time of mtRNA and its interaction with RIG-I, thereby modulating mtRNA-induced innate immunity. Thus, our work establishes in vitro models of mtRNA extrusion, and highlights m6A-dependent modulation as a potential therapeutic target for mtRNA-driven inflammation.

immunology↗